Active agent combination for treatment of cancer
Номер патента: EP4203944A1
Опубликовано: 05-07-2023
Автор(ы): Götz HARTLEBEN, Mauricio Berriel Diaz, Stephan Herzig, Tobias Schafmeier
Принадлежит: Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Опубликовано: 05-07-2023
Автор(ы): Götz HARTLEBEN, Mauricio Berriel Diaz, Stephan Herzig, Tobias Schafmeier
Принадлежит: Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Реферат: The present invention relates to a kit-of-parts comprising at least one mitochondrial uncoupler and at least one cationic amphiphilic drug and its use in medicine. The invention further relates to a pharmaceutical composition comprising at least one mitochondrial uncoupler and at least one cationic amphiphilic drug for use in medicine. Moreover, the invention is directed to the kit-of-parts and the pharmaceutical composition for use in the treatment of cancer, in particular glioma, pancreatic cancer, small cell lung cancer, metastatic prostate cancer, liver cancer and triple-negative breast cancer.
Active agent combination for treatment of cancer
Номер патента: WO2022043490A1. Автор: Stephan Herzig,Tobias Schafmeier,Mauricio Berriel Diaz,Götz HARTLEBEN. Владелец: Helmholtz Zentrum München - Deutsches Forschungszentrum Für Gesundheit Und Umwelt (GmbH). Дата публикации: 2022-03-03.